Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgery
Authors:
Open Access
- 17 July 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 16557
Abstract
Nicotinamide adenine dinucleotide (NAD +) plays a pivotal role in numerous cellular functions. Reduced NAD + levels are postulated to be associated with cancer. As interest in understanding NAD + dynamics in cancer patients with therapeutic applications in mind grows, there remains a shortage of comprehensive data. This study delves into NAD + dynamics in patients undergoing surgery for different digestive system cancers. This prospective study enrolled 99 patients with eight different cancers. Fasting blood samples were obtained during the perioperative period. The concentrations of NAD + , nicotinamide mononucleotide (NMN), and nicotinamide riboside were analyzed using tandem mass spectrometry. After erythrocyte volume adjustment, NAD + remained relatively stable after surgery. Meanwhile, NMN decreased the day after surgery and displayed a recovery trend. Interestingly, liver and pancreatic cancer patients exhibited poor postoperative NMN recovery, suggesting a potential cancer type-specific influence on NAD + metabolism. This study illuminated the behavior of NAD + in surgically treated cancer patients. We identified which cancer types have particularly low levels and at what point depletion occurs during the perioperative period. These insights suggest the need for personalized NAD + supplementation strategies, calibrated to individual patient needs and treatment timelines. Clinical trial registration jRCT1020210066.Keywords
All Related Versions
Funding Information
- NOMON Co. Ltd, Japan
This publication has 33 references indexed in Scilit:
- Stabilization and quantitative measurement of nicotinamide adenine dinucleotide in human whole blood using dried blood spot samplingAnalytical and Bioanalytical Chemistry, 2022
- DNA repair as a shared hallmark in cancer and ageingMolecular Oncology, 2022
- Age-associated differences in the cancer molecular landscapeTrends in Cancer, 2022
- Targeting cellular senescence to combat cancer and ageingMolecular Oncology, 2022
- Pan-cancer analysis reveals molecular patterns associated with ageCell Reports, 2021
- Evolving concepts in NAD+ metabolismCell Metabolism, 2021
- NAD+ metabolism: pathophysiologic mechanisms and therapeutic potentialSignal Transduction and Targeted Therapy, 2020
- Assessment of NAD+metabolism in human cell cultures, erythrocytes, cerebrospinal fluid and primate skeletal muscleAnalytical Biochemistry, 2019
- NAD+ and sirtuins in aging and diseaseTrends in Cell Biology, 2014
- Glucose metabolism is accelerated by exposure to t-butylhydroperoxide during NADH consumption in human erythrocytesBlood Cells, Molecules, and Diseases, 2008